Olaris Adds Strategic Investment from Bruker Corporation

“Olaris has developed a powerful platform for discovering actionable metabolomic biomarkers,” said Dr. Falko Busse, the President of the Bruker BioSpin Group. “We are excited to support their vision and collaborate on driving new applications of metabolomics in precision health.” Post this “We are thrilled to have Bruker as a strategic investor and partner,” said … Read more

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

SAN DIEGO, May 19, 2025 /PRNewswire/ — Cortechs.ai, a global leader in AI-driven neuroimaging solutions, today announced a strategic collaboration with the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) to enhance the quality of care for people living with Alzheimer’s disease. This collaboration brings together Cortechs.ai’s advanced imaging platform, NeuroQuant® for ARIA, with ALZ-NET’s robust … Read more

Penn Dental Medicine Study Shows Innate Immune Training Aggravates Inflammatory Bone Loss

PHILADELPHIA, May 1, 2025 /PRNewswire/ — Clinical research has long focused on ways to harness the actions of the immune system. From vaccines to immunotherapies, researchers have used their knowledge of the immune system to develop therapies to treat or prevent diseases from influenza to autoimmune disease and cancer. Now, researchers from Penn Dental Medicine and … Read more

New Study Reveals AI Mapping Technology, Unfold AI, Outperforms MRI in Predicting Prostate Cancer Spread

Presented at the American Urological Association’s 2025 Annual Meeting, this new data builds on Avenda Health’s previous study demonstrating Unfold AI’s ability to predict extracapsular extension risk, which was named winner of the BJUI Compass Prize 2025. CULVER CITY, Calif., May 1, 2025 /PRNewswire/ — Avenda Health, an AI healthcare company creating the future of … Read more

SeeTreat to Launch ART.1 to Support Adaptive Radiotherapy at ESTRO 2025

“We designed ART.1 to perform background analysis of every fraction, prioritizing major deviation, and give the clinical team a second set of eyes—without adding to the radiotherapy workload, resources or time.” – Trang Nguyen, CEO and founder of SeeTreat. Post this “Adaptive radiotherapy has traditionally been complex, costly, and limited to well-resourced centers,” said Trang … Read more

Recently Discovered Immune Cell Type Is Key to Understanding Food Allergies

NEW YORK, April 14, 2025 /PRNewswire/ — The immune system must be able to quickly attack invaders like viruses, while also ignoring harmless stimuli, or allergies can result. Immune cells are known to ignore or “tolerate” molecules found on the body’s own healthy cells, for instance, as well as nonthreatening substances from outside the body like … Read more

In pancreatic cancer, a race against time

COLD SPRING HARBOR, N.Y., April 2, 2025 /PRNewswire/ — Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it’s diagnosed, it’s often difficult to treat. So, for both individual patients and the general population, fighting pancreatic cancer can feel like a race against time. Cold Spring Harbor Laboratory (CSHL) Professor … Read more

Effectiveness of Epidural Steroid Injections for Chronic Back Pain

AAN Publishes Updated Systematic Review on Epidural Steroid Injections for Chronic Back Pain The American Academy of Neurology (AAN) has released a new systematic review aimed at helping… The post Effectiveness of Epidural Steroid Injections for Chronic Back Pain appeared first on NewsyList. Source link

Epidural Steroid Injections for Chronic Back Pain: An AAN Systematic Review

MINNEAPOLIS, Feb. 19, 2025 /PRNewswire/ — The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people with certain kinds of chronic back pain. The systematic review is published in the February 12, … Read more

Lumeda Reports Progress In Clinical Evaluation Of Its Intraoperative Photodynamic Therapy

Successful completion of a phase I clinical study for improving local control in patients with advanced colorectal cancer undergoing surgery ROCKY HILL, Conn., Jan. 27, 2025 /PRNewswire-PRWeb/ — Lumeda Inc. (“Lumeda”), a biophotonics systems company formed to advance photodynamic therapy (PDT) for treating cancer, today announced the completion of a phase 1 clinical by Roswell … Read more